Results 21 to 30 of about 28,965 (255)

RAF1–MEK/ERK pathway‐dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation

open access: yesJournal of Pathology, 2021
Ameloblastoma is an odontogenic neoplasm characterized by slow intraosseous growth with progressive jaw resorption. Recent reports have revealed that ameloblastoma harbours an oncogenic BRAFV600E mutation with mitogen‐activated protein kinase (MAPK ...
S. Fujii   +13 more
semanticscholar   +1 more source

Exploratory Advanced Radiotherapies for Ameloblastoma and Ameloblastic Carcinoma-A Concise Review. [PDF]

open access: yesOral Dis
ABSTRACT Objective Ameloblastoma is an aggressively growing odontogenic tumor with substantial management challenges and a high recurrence rate. Surgical resection is the treatment of choice for ameloblastoma, but adjuvant therapies like radiation have been explored in cases where surgery is not clinically advisable and the tumor is inoperable.
Turkstani H, Alfaifi A, Akintoye SO.
europepmc   +2 more sources

Enrichment of SOX2-Positive Cells in BRAF V600E Mutated and Recurrent Ameloblastoma

open access: yesJournal of Personalized Medicine, 2022
Ameloblastoma is the most common benign odontogenic neoplasm, but with an aggressive behavior and a high recurrence rate. Nowadays wide surgical resection is the current recommended treatment, which can cause further loss of function and esthetics ...
C. Tseng   +3 more
semanticscholar   +1 more source

Prevalence and Epidemiological Profile of Ameloblastoma in India: A Systematic Review and Meta-Analyses

open access: yesAsian Pacific Journal of Cancer Prevention, 2022
Introduction: Ameloblastoma is regarded as the second most prevalent odontogenic tumor in the light of its prevalence, clinical characteristics, greater incidence of tumor recurrence, and therapeutic challenges.
Yoithapprabhunath Thuckanaickenpalayam Ragunathan   +5 more
semanticscholar   +1 more source

Upfront rational therapy in BRAF V600E mutated pediatric ameloblastoma promotes ad integrum mandibular regeneration

open access: yesJournal of Tissue Engineering and Regenerative Medicine, 2021
Ameloblastoma is a neoplasm arising in the craniofacial skeleton. Proliferating odontogenic epithelial cells comprise this benign, yet locally invasive tumor, often causing severe disfiguration.
A. Hirschhorn   +9 more
semanticscholar   +1 more source

A Retrospective Study of 158 Cases on the Risk Factors for Recurrence in Ameloblastoma

open access: yesInternational Journal of Medical Sciences, 2021
Background: Ameloblastoma is an odontogenic tumor occurring in jaws, with local aggressiveness and postoperative recurrence. This study was aim to investigate the clinical and radiographic risk factors for recurrence in ameloblastoma.
L. Bi   +6 more
semanticscholar   +1 more source

Unicystic ameloblastoma in 3 year old paediatric patient: a rare entity [PDF]

open access: yes, 2013
Unicystic ameloblastoma (UA) is a benign epithelial odontogenic tumor of the jaws that commonly occurs in 2nd and 3rd decade of life. In fact, this entity is rare in children under 12 years of age.
Arora, Shelly   +3 more
core   +1 more source

Fluid aspirates of ameloblastoma: Types, prevalence, and prognostic relevance

open access: yesInternational Journal of Medicine and Health Development, 2022
Background: Ameloblastoma is a benign cystic odontogenic tumor common in Nigeria. The cystic cavities frequently contain tumor fluids, which may be obtained by needle aspiration. The tumor fluids help in the clinical differential diagnosis.
Mark C Nwoga
doaj   +1 more source

Malignant ameloblastoma metastasis to the neck: Radiological and pathohistological dilemma [PDF]

open access: yes, 2012
Introduction. Ameloblastomas are odontogenic epithelial, locally invasive tumors of slow growth and mostly of benign behavior. Their frequency is low (they account for 1% of all head and neck tumors and about 11% of tumors of dental origin). Malignant
Antunović Marija   +4 more
core   +1 more source

Recurrence Rates of Intraosseous Ameloblastoma Cases With Conservative or Aggressive Treatment: A Systematic Review and Meta-Analysis

open access: yesFrontiers in Oncology, 2021
Objective This study aimed to systematically investigate and compare the post-treatment recurrence of intraosseous ameloblastoma in patients treated with conservative or aggressive approaches.
Xue Qiao   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy